|
|
|
Heat Biologics Inc 
|
6.89 -0.2 (-0.03%) |
01-22 16:00 |
Open: |
6.96 |
Pre close: |
7.09 |
Target:
|
8.61
|
High: |
7.14 |
Low: |
6.8 |
Resistance:
|
7.37
8.61
|
Volume: |
803,839 |
Market Cap: |
157M |
Support:
|
6.04
5.22
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
6.86
 |
MACD |
MACD(12,26):
|
0.12  |
MA(20): |
6.05  |
Signal(12,26,9): |
-0.08  |
MA(100): |
7.57  |
Stochastic Oscillator |
%K(14,3):
|
83.72  |
MA(250): |
6.89  |
%D(3): |
81.79  |
Average Volume(K) |
3-Month: |
138904
|
52-Week |
High:
|
30.10 |
10-Days: |
124731 |
Low: |
1.40 |
RSI |
RSI(14):
|
60.54  |
Change(%): |
310.1 |
Financials, Statistics and Valuation |
EPS |
-1.990 |
Return on Equity (ttm) |
-33.7 |
Shares Out. (M) |
22.83 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.5 |
Shares Float (M) |
21.78 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.01 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
13096.6 |
% Held by Institutions |
12.27 |
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-0.436 |
Shares Short (K) |
2180 |
Book Value (p.s.) |
5.420 |
EBITDA (p.s.) |
-0.932 |
P/E |
-3.46 |
Sales Per Share |
0.190 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.27 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.83 |
P/S |
36.24 |
Operating Margin |
-496.59 |
Levered Free Cash Flow
(M) |
-9.58 |
P/CF |
-9.94 |
|
|
|
|
|